Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects
Publié dansBMC neurology, vol. 15, 182
Date de publication2015
Résumé
Structure d'affiliation
Groupe de recherche
Citation (format ISO)
PETERSEN, Jens A et al. Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects. In: BMC neurology, 2015, vol. 15, p. 182. doi: 10.1186/s12883-015-0449-3
Fichiers principaux (1)
Article (Accepted version)
Identifiants
- PID : unige:83967
- DOI : 10.1186/s12883-015-0449-3
- PMID : 26444858
ISSN du journal1471-2377